COMMUNIQUÉS West-GlobeNewswire

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
03/06/2026
LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“ RadNet ”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network [...]
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
03/06/2026
FULLERTON, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that it has entered into a warrant exercise agreement with existing accredited [...]
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
03/06/2026
- Expanded collaboration builds upon research momentum in developing next-generation bispecific immunotherapies using CytomX’s PROBODY ® and Regeneron's Veloci-Bi ® platforms - - CytomX to receive $37 million target [...]
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
03/06/2026
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 or early 2027 Novel [...]
Coloplast’s Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of men
03/06/2026
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be available in the U.S. in [...]
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
03/06/2026
SAN DIEGO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) [...]
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
03/06/2026
WILMINGTON, Del., June 03, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company, today announced the pricing of an [...]
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
03/06/2026
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- [...]
Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
03/06/2026
- Joint partnership leverages Alpha Tau’s highly potent, localized alpha-radiation technology and Tolmar’s commercial leadership to transform the U.S. uro-oncology landscape - Collaboration elevates prostate cancer as a [...]
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
03/06/2026
On track to complete enrollment of MIST Phase 2b trial of AP01 in progressive pulmonary fibrosis (PPF) in mid-2026, with newly presented long term open-label extension clinical data that support favorable tolerability [...]
Sparrow Pharmaceuticals Announces Acceptance of Late-Breaking Presentation of Interim Part 1 Results from CAPTAIN-T2D at the Endocrine Society (ENDO) 2026 Annual Meeting
03/06/2026
Sparrow will also present Phase 2 data on cardiometabolic improvements in patients with type 2 diabetes BOSTON, June 03, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals , a targeted cardiometabolic therapeutics company [...]
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
03/06/2026
RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing Bell on Wednesday, [...]
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
03/06/2026
Noctrix Health acquisition validates Angelini Ventures’ strategy of investing in innovative healthcare companies addressing significant unmet medical needs and advancing connected health Rome, Italy, 3 rd June 2026 – [...]
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
03/06/2026
Data presentations across multiple kidney diseases illustrate the breadth of Biogen’s nephrology portfolio with EMPAVELI® (pegcetacoplan) and felzartamab, an investigational anti-CD38 monoclonal antibody. CAMBRIDGE, [...]
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
03/06/2026
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of [...]
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
03/06/2026
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered deep B-cell depletion with evidence of immune reset Miv-cel continues to [...]
It's Not a Prenatal Class, It's a Social Club With a Curriculum for Parenthood — Launching in Miami This August
03/06/2026
Expecting Together is bringing clinician-led education, meaningful connection, and real community to expecting families across Miami MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- Miami has attracted transplants, globally [...]
Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
03/06/2026
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, today announced that Giorgio R. Saumat, CEO and [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/2026
NEW HAVEN, Conn., June 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on June 1, 2026, Invivyd granted 17 newly hired non-executive employees options to purchase an aggregate of 513,500 [...]

Pages